The role of neutralizing antibodies in hepatitis C virus infection.
Edwards, Victoria C; Tarr, Alexander W; Urbanowicz, Richard A; Ball, Jonathan K.
J Gen Virol
; 93(Pt 1): 1-19, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22049091
Hepacivirus A Infection in Horses Defines Distinct Envelope Hypervariable Regions and Elucidates Potential Roles of Viral Strain and Adaptive Immune Status in Determining Envelope Diversity and Infection Outcome.
Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A.
Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization.
Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1.
A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.
Novel E2 Glycoprotein Tetramer Detects Hepatitis C Virus-Specific Memory B Cells.
The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs.
Fine mapping of murine antibody responses to immunization with a novel soluble form of hepatitis C virus envelope glycoprotein complex.
Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization.
Structural analysis and epitope prediction of HCV E1 protein isolated in Pakistan: an in-silico approach.